Abordarea medico-chirurgicală a tumorilor pancreatice în urgență
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
324 2
Ultima descărcare din IBN:
2022-03-29 19:16
Căutarea după subiecte
similare conform CZU
616.37-006-07-08 (2)
Patologia sistemului digestiv. Tulburări ale tubului alimentar (1732)
SM ISO690:2012
GURGHIŞ, Radu, MALCOVA, Tatiana, GAGAUZ, Ion, GAFTON, Victor, SPATARU, Vasile, CRAVCENCO, Denis, ROJNOVEANU, Gheorghe. Abordarea medico-chirurgicală a tumorilor pancreatice în urgență. In: Chirurgia (București, Romania), 2020, vol. 115, supl. nr. 1, pp. 56-57. ISSN 1221-9118.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Chirurgia (București, Romania)
Volumul 115, Supliment nr. 1 / 2020 / ISSN 1221-9118

Abordarea medico-chirurgicală a tumorilor pancreatice în urgență

Medico-surgical approach to the pancreatic tumours in emergency

CZU: 616.37-006-07-08

Pag. 56-57

Gurghiş Radu1, Malcova Tatiana1, Gagauz Ion1, Gafton Victor2, Spataru Vasile2, Cravcenco Denis2, Rojnoveanu Gheorghe1
 
1 Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“,
2 IMSP Institutul de Medicină Urgentă
 
 
Disponibil în IBN: 14 aprilie 2021


Rezumat

Scop: analiza rezultatelor tratamentului miniinvaziv și chirurgical (paliativ æi rezecåional) la pacienåii cu tumori pancreatice (TP)
spitalizaåi în urgențã.
Material æi metodã: Studiu retrospectiv, 2014-2019, 185 pacienåi cu TP spitalizaåi în IMU, Chiæinãu, vârsta medie 63,91±10,98 ani,
raportul B:F/1,15:1. Cauza spitalizãrii: icter – 121(65,48%) cazuri, formațiune intraabdominalã - 41(22,16%), abdomen acut –
23(12,43%). Diagnosticul de TP a fost pus la: TC–129(69,73%); RMN–14(7,69%) și/sau CPGRE–102(55,14%), iar într-un caz intraoperator,
operat pentru peritonita. Localizare TP: cefalic – 163(89,56%) cazuri, corporeo-caudal - 22(11,89%). 35(19,23%) pacienåi
au fost refuzat orice procedura terapeuticã. S-au structurat trei loturi: lot.SE – stentare biliarã la CPGRE sau transparietohepatic,
lot.ABD – derivație biliodigestivã, lot.RP – rezecție pacnreaticã.
Rezultate: Lot.SE: 87(47,03%) cazuri, stentaåi endoscopic–79(90,80%), transparietohepatic–8(9,20%), vârsta–65,62±11,65ani,
bilirubinemia–222,0±122,0mmol/l, durata spitalizãrii–10,70±6,42zile, mortalitatea p/op - 9(10,34%). Lot.ABD: 25(13,74%) cazuri,
vârsta–61,2±10,87ani, bilirubinemia–86,0±17,0mmol/l, durata spitalizãrii¬–21,21±10,04zile, inclusiv–ATI–2,3±1,49zile, stentare
preoperatorie–7(28%)cazuri, mortalitatea p/op–4(16,0%). Lot.RP: 38(20,54%) cazuri, duodenopancreatectomie cefalicã –
27(71,05%) æi pancreatectomie distalã cu splenectomie–11(28,94%), vârsta–59,34±8,59ani, bilirubinemia–84,5±13,5mmol/l în TP
cefalice, stentaåi preoperator 8(29,63%) (bilirubinemia 218,5±85,74mmol/l), durata spitalizãrii–29,49±19,52zile, inclusiv
ATI–7,0±3,0zile, mortalitatea p/op-6(16,22%): rezecåie pancreatoduodenalã(5), pancreatectomie distalã(1).
Concluzii: Rata operaåiilor rezecționale cu viza de radicalitate rãmâne a fi sub limitatã mondialã raportatã din cauza adresabilitãåii æi
diagnosticului tardiv. Stentarea biliarã endoscopicã æi derivaåia biliodigestivã sunt cele mai frecvente opåiuni de rezolvare a TP
complicate cu sindrom colestatic. Mortalitatea postoperatorie în lotul ABD æi RP a fost similarã, dar durata spitalizãrii æi rata
complicaåiilor mai mare pentru RP.



Goal: analysis of mini-invasive and surgical (palliative and resectional) treatment results in patients with pancreatic tumours(PTs)
hospitalized in emergency.
Material and method: Retrospective study, 2014-2019, 185 patients with PT hospitalized in Institute of Urgent Care Medicine,
Chisinau, age 63,91±10,98years, M:W ratio 1,15:1. Cause of hospitalization: jaundice – 121(65,48%) cases, intra-abdominal tumour
− 41(22,16%), acute abdomen – 23(12,43%). The diagnosis of PT was established by: CT–129(69,73%); NMR–14(7,69%) and/or
ERCP–102(55,14%), and in one case intraoperative, operation for peritonitis. PT localization: head of pancreas – 163(89,56%)
cases, body or tail − 22(11,89%). 35(19,23%) patients refused any therapeutic procedure. The patients were divided into three
groups: group.ES – biliary stenting through ERCP or transparietohepatic, group.BDD – biliodigestive derivation, group. PR –
pancreatic resection.
Results: Group.ES: 87(47,03%) cases, endoscopic stenting–79(90,80%), transparietohepatic–8(9,20%), age–65,62±11,65years,
serum bilirubin level–222,0±122,0mmol/l, hospitalization time–10,70±6,42days, postoperative mortality−9(10,34%).
Group.BDD: 25(13,74%) cases, age–61,2±10,87years, serum bilirubin level–86,0±17,0mmol/l, hospitalization
time–21,21±10,04days, ICU length of stay–2,3±1,49days, preoperative stenting–7(28%)cases, postoperative mortality–4(16,0%).
Group.PR: 38(20,54%) cases, cephalic duodeno-pancreatectomy–27(71,05%) and distal pancreatectomy with splenectomy–
11(28,94%), age–59,34±8,59years, serum bilirubin level–84,5±13,5mmol/l in pancreatic head tumour, preoperative stenting
8(29,63%) (serum bilirubin level 218,5±85,74mmol/l), hospitalization time–29,49±19,52days, ICU length of stay–7,0±3,0days, postoperative mortality−6(16,22%): pancreaticoduodenal resection(5), distal pancreatectomy(1).
Consclusions: The rate of radical resection surgeries remains to be under global level due to late addressability and diagnosis. Endoscopic
biliary stenting and biliodigestive derivation are the most frequent treatment options for the PT complicated by jaundice. Postoperative
mortality in the groups BDD and PR is similar, but the hospitalization time and complication rate is higher in group PR.



Cuvinte-cheie
formațiune pancreaticã, stentare biliarã endoscopicã, drenare transparietohepaticã, derivaţie biliodigestivă, rezecție pancreaticã,

pancreatic tumour, endoscopic biliary stenting, transparietohepatic drainage, biliodigestive derivation, Pancreatic resection